Amryt Pharma Plc - Company Profile
Powered by
All the data and insights you need on Amryt Pharma Plc in one report.
$295
- Save hours of research time and resources with
our up-to-date Amryt Pharma Plc Strategy Report
- Understand Amryt Pharma Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Amryt Pharma Plc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
18 Dec 2023 | Amryt Pharmaceuticals Enters Manufacturing Agreement with Lichtenheld for Filsuvez | Contract Service Agreement |
Amryt Pharmaceuticals DAC
|
Lichtenheldt GmbH
|
08 Jan 2023 | Chiesi Farmaceutici Acquires Amryt Pharma | Acquisition |
Chiesi Farmaceutici SpA
|
Amryt Pharma Plc |
05 May 2021 | Amryt Pharma Acquires Chiasma | Acquisition |
Amryt Pharma Plc
|
Chiasma Inc |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer